Evidence map›Paper›PMID 38682281›Full record

ArticleBiopreservation and biobanking2024

The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks.

Hein S Zelisse, Sander de Ridder, Mignon D J M van Gent, Constantijne H Mom, G Bea A Wisman, Eva-Maria Roes, Anna K L Reyners, Jurgen M Piek, Gatske M Nieuwenhuyzen-de Boer, Christianne A R Lok and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biopreservation and biobanking, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Hein S ZelisseDepartment of Pathology, Cancer Center Amsterdam, Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Sander de RidderDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Mignon D J M van GentDepartment of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Constantijne H MomDepartment of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
G Bea A WismanDepartment of Gynaecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Eva-Maria RoesDepartment of Gynecologic Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Anna K L ReynersDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Jurgen M PiekDepartment of Obstetrics and Gynaecology, Catharina Hospital, Catharina Cancer Institute, Eindhoven, the Netherlands.
Gatske M Nieuwenhuyzen-de BoerDepartment of Gynaecology and Obstetrics, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Christianne A R LokDepartment of Gynaecological Oncology, Centre for Gynaecologic Oncology Amsterdam, Antoni van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Cornelis D de KroonDepartment of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, the Netherlands.
Loes F S KooremanDepartment of Pathology and GROW, School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Marc-Jan JanssenDepartment of Gynecological Oncology, Medisch Spectrum Twente, Enschede, the Netherlands.
Maurice P H M JansenDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Hugo M HorlingsDepartment of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Margriet ColléeDepartment of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Annegien BroeksDepartment of CFMPB (Core Facility - Molecular Pathology and Biobanking), The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ingrid A BoereDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Joost BartDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Anne M van AltenaDepartment of Obstetrics & Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
Marlou HeelingDepartment of Pathology, Cancer Center Amsterdam, Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
I Matthijs StoterDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Quirinus J VoorhamPalga Foundation, Houten, the Netherlands.
Marc J van de VijverDepartment of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Frederike DijkDepartment of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Jeroen A M BelienDepartment of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Archipelago of Ovarian Cancer Research ConsortiumORCID 0000-0003-4155-6331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological Specimen BanksOvarian NeoplasmsFemaleHumansInformation TechnologyNetherlandsSoftwarebiobankblueprintinformation technology (IT) infrastructureovarian cancerresearch infrastructure

Identifiers

PMID38682281
PMCPMC11671660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.